Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction

Abstract Early depressive symptoms within the first days after acute myocardial infarction (AMI) are mainly manifested with performance parameters (lack of energy, concentration difficulties, reduction in physical functioning). Homoarginine (hArg), a non-proteinogenic amino acid, might increase the...

Full description

Saved in:
Bibliographic Details
Main Authors: Andreas Baranyi, Andreas Meinitzer, Dirk von Lewinski, Jolana Wagner-Skacel, Sabrina Leal Garcia, Hans-Bernd Rothenhäusler, Omid Amouzadeh-Ghadikolai, Leonhard Harpf, Melanie Schweinzer, Dietmar Enko
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84930-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544731249606656
author Andreas Baranyi
Andreas Meinitzer
Dirk von Lewinski
Jolana Wagner-Skacel
Sabrina Leal Garcia
Hans-Bernd Rothenhäusler
Omid Amouzadeh-Ghadikolai
Leonhard Harpf
Melanie Schweinzer
Dietmar Enko
author_facet Andreas Baranyi
Andreas Meinitzer
Dirk von Lewinski
Jolana Wagner-Skacel
Sabrina Leal Garcia
Hans-Bernd Rothenhäusler
Omid Amouzadeh-Ghadikolai
Leonhard Harpf
Melanie Schweinzer
Dietmar Enko
author_sort Andreas Baranyi
collection DOAJ
description Abstract Early depressive symptoms within the first days after acute myocardial infarction (AMI) are mainly manifested with performance parameters (lack of energy, concentration difficulties, reduction in physical functioning). Homoarginine (hArg), a non-proteinogenic amino acid, might increase the availability of nitric oxide (NO). NO controls vasodilatation, blood flow, mitochondrial respiration and improves performance. Therefore, low plasma hArg levels after an AMI might impact performance-related early depressive symptoms. This longitudinal study aims to determine the course of plasma hArg concentrations immediately, on the fourth day and 6 months after AMI and investigates the associations between hArg and early depressive symptoms. A decrease in hArg levels, as observed in AMI patients on the fourth day after AMI, was independent of gender, age, body-mass-index and AMI type. After six months, hArg concentrations no longer differed significantly from baseline values. Females had lower hArg concentrations shortly after and also four days after the AMI compared to males. Within the first days after AMI HAMD-17 and BDI-II total depression scores and performance-related early depressive symptoms such as lack of energy, concentration difficulties and reduction in physical functioning correlated with low hArg concentrations.
format Article
id doaj-art-3cdac11145ef4e6080419d8e7f207a74
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-3cdac11145ef4e6080419d8e7f207a742025-01-12T12:18:30ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-024-84930-yHomoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarctionAndreas Baranyi0Andreas Meinitzer1Dirk von Lewinski2Jolana Wagner-Skacel3Sabrina Leal Garcia4Hans-Bernd Rothenhäusler5Omid Amouzadeh-Ghadikolai6Leonhard Harpf7Melanie Schweinzer8Dietmar Enko9Department of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Division of Psychiatry and Psychotherapeutic Medicine, Medical University of GrazClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of GrazDepartment of Internal Medicine, Division of Cardiology, Medical University of GrazDepartment of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Division of Medical Psychology, Psychosomatics and Psychotherapeutic MedicineDepartment of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Division of Medical Psychology, Psychosomatics and Psychotherapeutic MedicineDepartment of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Division of Psychiatry and Psychotherapeutic Medicine, Medical University of GrazGFSG - Gesellschaft Zur Förderung Seelischer Gesundheit GmbHPRO-DOCDepartment of Psychiatry, Psychosomatics and Psychotherapeutic Medicine, Division of Psychiatry and Psychotherapeutic Medicine, Medical University of GrazClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of GrazAbstract Early depressive symptoms within the first days after acute myocardial infarction (AMI) are mainly manifested with performance parameters (lack of energy, concentration difficulties, reduction in physical functioning). Homoarginine (hArg), a non-proteinogenic amino acid, might increase the availability of nitric oxide (NO). NO controls vasodilatation, blood flow, mitochondrial respiration and improves performance. Therefore, low plasma hArg levels after an AMI might impact performance-related early depressive symptoms. This longitudinal study aims to determine the course of plasma hArg concentrations immediately, on the fourth day and 6 months after AMI and investigates the associations between hArg and early depressive symptoms. A decrease in hArg levels, as observed in AMI patients on the fourth day after AMI, was independent of gender, age, body-mass-index and AMI type. After six months, hArg concentrations no longer differed significantly from baseline values. Females had lower hArg concentrations shortly after and also four days after the AMI compared to males. Within the first days after AMI HAMD-17 and BDI-II total depression scores and performance-related early depressive symptoms such as lack of energy, concentration difficulties and reduction in physical functioning correlated with low hArg concentrations.https://doi.org/10.1038/s41598-024-84930-yAcute myocardial infarctionHomoarginineEarly depressive symptomsPhysical functioning
spellingShingle Andreas Baranyi
Andreas Meinitzer
Dirk von Lewinski
Jolana Wagner-Skacel
Sabrina Leal Garcia
Hans-Bernd Rothenhäusler
Omid Amouzadeh-Ghadikolai
Leonhard Harpf
Melanie Schweinzer
Dietmar Enko
Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
Scientific Reports
Acute myocardial infarction
Homoarginine
Early depressive symptoms
Physical functioning
title Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
title_full Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
title_fullStr Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
title_full_unstemmed Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
title_short Homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
title_sort homoarginine concentrations correlate with early depressive symptoms and the reduction in physical functioning within the first days after myocardial infarction
topic Acute myocardial infarction
Homoarginine
Early depressive symptoms
Physical functioning
url https://doi.org/10.1038/s41598-024-84930-y
work_keys_str_mv AT andreasbaranyi homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT andreasmeinitzer homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT dirkvonlewinski homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT jolanawagnerskacel homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT sabrinalealgarcia homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT hansberndrothenhausler homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT omidamouzadehghadikolai homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT leonhardharpf homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT melanieschweinzer homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction
AT dietmarenko homoarginineconcentrationscorrelatewithearlydepressivesymptomsandthereductioninphysicalfunctioningwithinthefirstdaysaftermyocardialinfarction